FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Intelgenx Technologies's Free Cash Flow for the
three
months ended in Dec. 2023 was $-0.59 Mil. Intelgenx Technologies's Revenue for the
three
months ended in Dec. 2023 was $0.43 Mil. Therefore, Intelgenx Technologies's FCF Margin % for the quarter that ended in Dec. 2023 was -138.26%.
As of today, Intelgenx Technologies's current FCF Yield % is -23.42%.
The historical rank and industry rank for Intelgenx Technologies's FCF Margin % or its related term are showing as below:
IGXT'
s FCF Margin % Range Over the Past 10 Years
Min: -1175.74 Med: -427.84 Max: -11.44
Current: -645.33
During the past 13 years, the highest FCF Margin % of Intelgenx Technologies was -11.44%. The lowest was -1175.74%. And the median was -427.84%.
IGXT's FCF Margin % is ranked worse than 69.61% of 1030
companies
in the Biotechnology industry
Industry Median: -148.935
vs IGXT: -645.33
Intelgenx Technologies FCF Margin % Historical Data
The historical data trend for Intelgenx Technologies's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Intelgenx Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelgenx Technologies FCF Margin % Distribution
For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Intelgenx Technologies's FCF Margin % falls into.
Intelgenx Technologies FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Intelgenx Technologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelgenx Technologies FCF Margin % Related Terms
Thank you for viewing the detailed overview of Intelgenx Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Intelgenx Technologies (Intelgenx Technologies) Business Description
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IGXT has been successfully added to your 